ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Neurotrope Announces Agreement for Bryostatin-1 with National Cancer Institute
February 19, 2019Neurotrope has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the research and clinical development of Bryostatin-1..... -
Drug Company Payments Over Time May Influence Rx Practices
February 14, 2019Physicians treating certain cancers who consistently receive payments from a cancer drug's manufacturer are more likely to prescribe that drug instead of other treatments, according to a study published online Feb. 6 in The Oncologist.... -
NCI awards contract to PACT & Health of Branford, CT, USA
September 25, 2017An integrated platform to screen anti-cancer drugs using high-throughput clonogenic assay will be designed -
SillaJen and NCI partner to develop new colorectal cancer treatment
August 21, 2017Korean-based SillaJen has entered a cooperative research and development agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), US, to develop a new combination therapy for colorectal cancer (CRC). -
Research by NCI determines necessary genes for cancer immunotherapy
August 09, 2017The research could accelarate the advancement of a new category of drugs.
Pharma Sources Insight January 2025
